4//SEC Filing
Riggs Josh 4
Accession 0001493152-23-029347
CIK 0001642380other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 6:57 PM ET
Size
5.6 KB
Accession
0001493152-23-029347
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Award
Option to Purchase Common Stock
2023-08-15+40,000→ 40,000 totalExercise: $3.34Exp: 2033-08-15→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The options will vest and thereby be exercisable on December 31, 2025, based on achievement of certain specified targets with respect to the 30-day volume-weighted average price of Company's common stock, measured as of the end of each full calendar month up through December 31, 2025, subject to continuous services through December 31, 2025.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001956391
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 6:57 PM ET
- Size
- 5.6 KB